Summary: Light scattering due to the formation of insoluble complexes between the long-chain quaternary ammonium sah N-cetylpyridinium chloride and glycosaminoglycans was utilized for a relative simple, sensitive and precise determination of total and specific types of glycosaminoglycans by laser nephelometry. The addition of the ammonium salt to Solutions of various glycosaminoglycans in 0.03 mol/1 NaCl produces a time-dependent increase in light scattering, which reaches a maximum between 14 and 18h of complex formation, irrespective of the type of glycosaminoglycan studied. Only keratan sulphate does not generate light scattering, and is therefore not detectable by the procedure. The scattering of laser light by certain types of sulphated glycosaminoglycans (e.g. heparan sulphate, heparin) depends more on the degree of sulphation (charge density) than on chain length within a certain ränge. Optimum light scattering was found at 28 mmol/l N-cetylpyridinium chloride and at a ionic strength around 0.03 mol/1 NaCl.
reaktion (Glucuronsäure) erweist sich die Lasernephelometrie als mindestens 8 mal empfindlicher und
Introduction
Glycosaminoglycans are complex linear (unbranched) heteropolysaccharides which are covalently linked to a core protein forming a high molecular weight proteoglycan (1) (2) (3) (4) . With the exception of hyaluronic acid, which is not covalently bound to a protein moiety, the components of the serially repeating disaccha^de unit are substituted with sulphate residues, thus giving the total molecule a highly anionic Charge. Due to variations in the composition of the disaccharide unit (usually N-acetylglucosamine, N-acetylgalactosamine and glucuronic acid, iduronic acid), in the Charge density, in the distribution of sulphate residues between glucuronic acid and hexosamine, and in the chain length (molecular weight), glycosaminoglycans comprise a greatly heterogeneous class of carbohydrates with a high degree of molecular polydispersity (5) .
Glycosaminoglycans are main constituents of the intercellular matrix in tissues such äs cartilage, skin and cornea (4) but are also present in parenchymatous organs like liver (6), brain (7, 8) , and kidney (9, 10) . In the latter type of tissues glycosaminoglycans are also distributed intracellularly (10, 12) and pericellularly (9, 13, 14) . This subcellular localization suggests that glycosaminoglycans may have some äs yet unknown regulatory role, in addition to their mechanical functions in the intercellular compartment. The presence of glycosaminoglycans not oftly in tissues but also in several body fluids, e.g. serum (15) (16) (17) , urine (18) , amniotic fluid (19) , and synovial fluid (20) has been well documented. Although characteristic changes of the total amount and, more seldom, of the pattern of glycosaminoglycans in serum and urine have been described in acquired (21) (22) (23) (24) (25) and hereditary (26) (27) (28) (29) diseases, our present knowledge of the possible pathobiochemical or diagnostic significance of these alterations is limited. This failure is partly due to the difficulties inherent in the methods of determination.
The structural diversity of glycosaminoglycans and some of their structural similarities to glycoproteins have seriously complicated the development of analytic procedures with both sensitivity and specificity for the individual types of glycosaminoglycans. Whereas ion^exchange chromätogiaphic Separation and differential extraction or fractionatiön of glycosaminoglycans are valüable fesearch tools (30) these methods are too laborious for applicaticm in the röu-tine laboratory. Electrophoresis of glycosaminoglycans, using a öne-dimensional (31^33), öf tw<>di-mensional System (34, 35) has been suggested äs a method suitable for routine analysis, but incomplete Separation of the bands partly due to the heterogeneity of individual glycosaminoglycans and species Variation between tissue or fluid and reference glycosaminoglycans are frequent limiting factors in the identification of glycosaminoglycans. For routine purposes the fofmätion of insoluble complexes between anionic polysaccharides and a variety of cation ie substances has been utilized in a great number of modifications (30, 36). The glyeosaminogiycan-precipitating ability of the cationic dye Alcian Blüe 8GX (37) has been exploited for quantitative measurement of glycosaminoglycans in urine (38, 39) and serum (40) , respectively, but the specificity of the method in complex biological fluids is limited (4l).
The introduction of long-chain quaternary ammonium salts such äs N-cetylpyridinium Chloride and cetyltrimethylammonium brpmide (42, 43) äs precipitating agents of glycosaminoglycans has greatly facilitated the development of relatively simple and reliable procedures for their quantitation and Isolation. Both quaternary ammonium salts have been applied for the measureiiient of glycosaminoglycans in serum (45, 46) and urine (22, 23, 24, 44) , respectively. A further improvement of practicability was achieved by utilizing the formation of relatively iiisöluble complexes between cetyltrimethylammonium bromide and N-cetylpyridinium Chloride, respectively, and glycosaminoglycans in a turbidimetric assay of the latter in body fluids (47) (48) (49) . Although this analytic principle offers a convenient method for the determination of glycosaminoglycari^, the relatively low sensitivity proves to be disadvantageous. In the present study, we have used this method of complex formation, and we have combined the advantage of a homogeneous assay System with the sensitivity provided by laser nephelometry for the rneasurement of glycosaminoglycans in fluids.
Individual glycosaminoglycans were identified by their selective chemical and enzymatic destruction. A preliminary description of the method has been given elsewhere (50) . After completion of the present studies, Warren and Manley (51) reported on a laser nephelometric measurement of glycosaminoglycans in human serum. (54) , heparan suphate (Upjohn Comp. Kaiarnazoo, USA) from pig mucosa was repurified and separated by Dowex chromatography into low and highly sulphated subfractions with sulfale/glucosamine molar ratios of 0.31 and 2.40, respectively; heparin (Upjohn Comp.) frorri pig rhucosa, with a sulfate/glucosamine molar ratio of 1.87, was separated into a low (< 4000) and a high molecular weight fraction; hyaluronic acid was isolated from human synovial fluid.
Materials and Methods

Chondroitin
Preparation of samples
Synovial fluids were obtained by puncture from diseased joints. The condition of the diseased joints was classified äs inflammatory or n on-inflammatory according to cytological, clinicalrchemical and physico-chemical criteria (55, 56) . To remove the cells the synovial fluids were centrifuged for 15 min, 1500g, 25 °C and the cell-free supernatant kept at ^20 °C until analysis was performed. The material was diluted l : 40 with 0.03 mol/1 NaCI and filtered through Millex filters before Nrcetylpyridinium Chloride was added äs described below.
Determination of purified glycosaminoglycans by 'laser lighf scattering
Unless otherwise stated the principle procedure for the measurement of glycosaminoglycans was äs follows. Highly concentrated stock Solutions (l g/l) of the various glycosaminoglycans in 0.03 mol/1 NaCI were prepared and diluted geometricälly with 0.03 mol/I NaCI to obtain the final concentrations. The various dilutions were filtered through Millex disposable filters (MiHipore GmbH, Neu-Isenburg, FRG) and the 'light scattering, normally between 0.06 and 0.08 V, was measurcd. N-cetylpyridinium Chloride was used äs a 0.28 mol/1 solution in 0.03 mol/1 NaCI and filtered äs above. Light scattering of this solution was lower than 0.03 V.
200 of the Solutions of glycosaminoglycans were mixed in LNcuvettes (Behring Werke AG, Marburg, FRG) with 0.1 volume (20 ) ofthe N-cetylpyridinium Chloride solution and incubated for various' times, routinely 24 h, at room temperature. Before measurement the mixture was thoroughly whirled. The intensity of light scattering (voltage. V) was determined in a helium-neon laser nephelometer (wave length 632.8 nm, Behring Werke AG, Marburg) equipped with an automatic cuvette transport system and a Hewlett-Packard 9815 A microcomputer. For the final calculation light scattering of blank incubations was subtracted from those of the complete N-cetylpyridinium chloride-glycosaminoglycan mixture.
Determination ofspecific glycosaminoglycans in synfheiic mixtures of purified glycosaminoglycans and in body fluids by laser light scattering
Mixtures of different glycosaminoglycans, of which the concentration and the laser light scattering of the individual compounds were known, were prepared in 0,03 mol/1 NaCI and subjected to chemical and enzymatic treatment äs described previously (57) .
For estimation of N-suIphated glycosaminoglycans (heparan sulphate, heparin) the assay, total volume 1.20 ml, contained 1.0 ml glycosaminoglycan solution, O.lml of 1.5 mol/1 NaNÜ2 and 0.1 ml l : 5 diluted glacial acetic acid. The control incubation had a'similar composition but NaNOa was omitted. Light scattering by the blank incubations (without added cetylpyridinium Chloride) of both assay and control was similar and lower than 0.1 V: it was therefore neglected. The mixtures were incubated for 80 min at 37 °C, heated (100°C, l min), cooled and centrifuged (4min, 2000g). 0.12ml N-cetylpyridinium Chloride solution was added to the filtered supernatant, mixed and used for light scattering measurement äs described above.
The fraction of heparan sulphate and heparin in the mixture was calculated from the difference in the light scattering intensity between assay and control incubation.
The proportion of chondroitin sulphate in the mixtures was determined by degradation with chondroitin AC lyase (EC 4.2.2.5) (58). The assay, total volume 0.60 ml, contained 0.3 ml glycosaminoglycan solution, 0.1 ml "enriched" Tris-HCl buffer. pH 8.0 and 0.2 ml (l unit) chondroitin AC lyase. The proportion of chondroitin sulphate + dermatan sulphate was determined similarly, but the assay contained 0.2 ml (l unit) of chondroitin ABC lyase (EC 4.2.2.4) instead of AC lyase. The control incubations were composed sirnilarly but enzymes were omitted. Blank incubations (without N-cetylpyridinium Chloride) of both assay and control gave similar, low light scattering (<0. l V), and were therefore neglected. After incubation for 3h at 37 °C the mixtures were heated at 100 °C for l min, cooled, centrifuged for 4 min at 2000 g and the supernatant filtered through Millex filters. After addition of 0.06 ml N-cetylpyridinium Chloride solution light scattering was measured äs above.
The fraction of chondroitin sulphate + dermatan sulphate was calculated from the difference in the light scattering between the ABC lyase assay and the control incubation. The fraction of chondroitin sulphate was calculated from the respective difference between the AC lyase assay and control incubation, and the fraction of dermatan sulphate was calculated from the difference in the light scattering between the AC-lyasc and ABC-lyase assay of which the control incubations are identical. It should be noted that due to the partial degradation of hyaluronate by chondroitin lyases the procedure is only valid if hyaluronate is either absent from the mixture or has been rcmoved by digestion with hyaluronate lyase.
The portion of hyaluronic acid in the mixture of glycosaminoglycans was measured by selective destruction ofthe glycosaminogly- (57, 59) . The assay, total volume 1.5ml, contained 0.5ml glycosaminoglycan solution, 0.5 ml 0.1 mol/1 sodium acctate. pH 5.0 and 0.5 ml hyaluronatc lyase (250 units).
The control incubation did not contain hyaluronate lyase but otherwise had a similar composition. The respectivc blank incubation was omitted. The mixtures were incubated for 20 h at 37 °C and processed äs dcscribcd for chondroitin sulphate. After addition of 0.15 ml N-cetylpyridinium Chloride solution the intensity of scattered light was recorded äs mentioned above. The fraction ofhyaluronic acid was calculated from the difference in thc light scattering between assay and control incubation.
If the concentrations (mg/1) rather than the relative fractions of specific glycosaminoglycans are required, the intensity of light scattering of the individual glycosaminoglycans determined äs above is refered to a calibration curve of known concentrations of the respective, highly purified type of glycosaminoglycan. The specific types used äs references are described in the legends to the tables and figures. Special care was taken to ensure that light scattering was in the linear ränge of glycosaminoglycan concentration by measuring various dilutions in 0.03 mol/1 NaCl of the glycosaminoglycan-containing samples, e.g. urine, synovial fluid and arteficial mixtures.
Determination of glycosaminoglycans by turbidimetry
The solution of glycosaminoglycans and the incubation with N-cetylpyridinium Chloride were exactly äs described for nephelometry. The turbidity of the glycosaminoglycan-N-cetylpyridinium Chloride mixture was read at 340 nm using a centrifugal fast anä-lyzer (GEMSAEC Electro Nucleonics, USA). Only the absorbance of the first reading was recorded because subsequent readings (reading interval 60 s) produced false low absorbance values due to a Sedimentation of the glycosaminoglycan-N-cetylpyridinium Chloride complex. All measurements were performed at least in triplicate.
Other analylical procedures
Uronic acid was determined according to the Bitter & Muir modification (60) of the carbazole reaction introduced by Dische (61). The analysis was mechanized by adaptation to a Technicon Autoanalyzer II System.
Results
Characteriiation of the glycosammoglycan-N-cetylpyridinium Chloride complex formation by laser light scattering measurements
The addition of N-cetylpyridinium Chloride to various Solutions of specific glycosaminoglycans in 0.03 mol/1 NaCl produces a time dependent iiicrease in laser light scattering ( fig. 1 ). The rate of increase is influenced by the concentration of glycosaminoglycan because being higher for more concentrated Solutions ( fig. Ib, c) . Although the time-course varies slightly between the various types of glycosaminoglycans the maximum intensity of scattered light was recorded between 14 and 18 h of complex formation, independent of the type and the concentration of the glycosaminoglycan studied ( fig. 1 ). Significant differences in the concentration dependency of laser light scattering were found between the specific types of glycosaminoglycans (figs. 2, 3, 4). Chondroitin sulphate develops a more inteiise light scattering than dermatan sulphate whereas keratan sulphate is unable to pfoduce light scattering in the presence of N-cetylpyridiniuin v thloride ( fig. 2) . Thus, the latter type of glycosaminoglycan cannot be measured by the laser nephelometric method. The intensity of light scattering is independent of the presence or absence of sulphate groups in the carbohydrate chain. This is documented in figure 3 which shows for hyahironic acid a much stronger dose-dependent increase of light scattering (l in The conditions of the assay were äs described in figurc 2. fig. 3 ) than for glycosaminoglycan polysulphate (2 in fig. 3 ), a chemically over-sulphated chondroitin sulphate with a sulphate/hexosamine molar ratio of 4.0. However, different degrees of sulphation of heparan sulphate influence significantly the development of laser light scattering in the presence of N-cetylpyridinium Chloride (fig. 4) . Similar concentrations of a higher sulphated subfraction (sulphate/hexosamine molar ratio 2.4) produces much more light scattering than the lower sulphated fraction (sulphate/hexosamine molar ratio 0.31) (fig. 4) . Two types of heparin, differing in the chain length but having identical sulphate/hexosamine molar ratios of l .87, generate similar light scattering curves (fig. 4) . Thus, for the property of scattering laser light the degree of sulphation of a certain type of glycosaminoglycan seems to be more important than certain variations of the lengths of the carbohydrate chain.
Although the final concentration of N-cetylpyridinium Chloride in the assay, routinely 28 mmol/I, can be varied over a wide ränge without affecting the intensity of scattered light (täb. 1), care has to be taken that the cpncentration of the ammonium salt is in excess of that of the glycosaminoglycans. Otherwise falsely low concentrations of glycosaminoglycans may be recorded, due to reduced light scattering. In table 3 the linear ranges and detection limits of the laser nephelometric determinations of various, purified glycosaminoglycans are listed. The detection limit is defined s the result which is clearly different from the matrix (a solution of 28 mmol/1 Ncetylpyridinium chloride in 0.03 mol/1 NaCl), defined s 3 Standard deviations of the appropriate blank value (62) . If based on a detection limit of the carbazole reaction (60) of about 10 μιηοΐ/ΐ uronic acid and an uronic acid content of chondroitin sulphate of 1.3 μπιοΐ/mg, the laser nephelometric detection limit of l mg/1 chondroitin sulphate (tab. 3) corresponds to an uronic acid Concentration of 1.3μιήο1/1. Thus, laser nephelometry proves to be about 8 times more sensitive than quahtitation of chondroitin sulphate by the carbazole method. Taking-into account a minimum filling volume of the laser nephelometry cuvette of 0.2 ml, laser nephelometry enables the precise determination of an amount of glycosaminoglycan equivalent to 0.25 nmol uronic acid. As already mentioned keratan sulphate is not measurablb by to procedure.
Tab. 3. Detection limits and linear ranges of the laser nephelometric determination of various glycosaminoglycans. The glycosaminoglycans described in "Materials" were dissolved in 0.03 mol/1 NaCl. The detection limit, defined s the analytical result which is clearly detectable and different from the blank value (3 Standard deviations of the blank value) was assessed by succe^sive dilutions of a stock solution. Addition of N-cetylpyridinium chloride and incubation were s described in "Methods". Tab. 5. Recovery of individual glycosaminoglycans in a synthetic mixture of 4 specific, highly purified glycosaminoglycans by chcmical and cnzymatic treatment followed by lascr light scattering measurements. A solution containg dermatan sjulphate (40 mg/I), chondroitining sulphate (10 mg/1), heparan sulphate (10 mg/1), and hyaluronic acid (5 mg/1) in 0.03 mmol/1 NaCl wasprepared. The light scattering of eadh type of glycosaminoglycan at the respective concentraiion was determined separately to obtain the fraction of total light scattering due .to a specific type. Then, the mixture was sequentially degraded with nitrous acid, hyaluronale lyase and chondroitin AC/ABC lyases to mcasure the scattered light due to hcparan sulphate, hyaluronic acid, chondroitin sulphate, and dermatan sulphate, respectively, äs described in "Methods". The type-specific scattered light measured is expressed äs fraction (recovery) of that determined for the respective glycosaminoglycan separately. reduction of light scattering obtained by degradation of N-sulphated glycosaminoglycans, i.e. heparin and heparan sulphate, with nitrous acid, by degradation of hyaluronic acid with hyaluronate lyase, arid by degradation of chondroitin sulphate and dermatan sulphate with chondroitin AC and ABC lyases. Due to the limited specificity of chondroitin lyases, which also degrade to a certain extent hyaluronate, the digestion of the latter type of glycosaminoglycan with hyaluronate lyase should be performed before the chondroitin lyases are used. Hyaluronate lyase proves to be specific for hyaluronic acid (57) . Applying this approach füll recovery of the individual types in a complex synthetic mixture of 4 glycosaminoglycans is achieved (tab. 5), which indicates both the specificity and sensitivity of the procedure. However, care has to be taken with the control incubations because they scatter laser light more intensely (about 2 to 4 V) than the non-treated, native samples.
The possible interference of polynucleotides with the laser nephelometric assay was studied. Concentrations of ribosomal RNA up to 13 mg/1 produce light scattering lower than 0.1 V. A similar concentration of high molecular weight DNA scatters laser light at an intensity of 3.2 V in the presence of Nhcetylpyridinium Chloride. Concentrations of DNA lower than 6 mg/1 were without significant effect on light scattering (<0.1 V). Thus, physiologic Concentrations of DNA and RNA in body fluids, which are far below those tested here, are unlikely to affect the laser nephelometric estimation of glycosaminoglycans.
Comparison of the laser nephelometric and turbidimetric measurement of specific types of glycosaminoglycans
In relation to nephelometry the turbidimetric assay of glycosaminoglycans proves to be quite insensitive 
Laser nephelometric determination of the relative concentration and composition of glycosaminoglycans in synovial fluids
Based on clinical-chemical, cytological and physicochemical criteria (56) , synovial fluids (n = 38) were subdivided into those of inflammatory and non-inflammatory origin and subjected to a laser nephelometric determination of the relative concentration of glycosaminoglycans (light scattering units/ml synovial fluid). It was found that synovial fluids from non- ). The conditions of incubation were äs descrtibed in fig. 2 , and the absorbance at 340 nm was read using a centrifugal fast analyzer.
inflammatory joint diseases contain about 4.5 times more light scattering units/ml than those of inflammatory diseases. However, a considerable interindividual Variation was noted (tab. 7). A fraction of more than 0.98 of the N-cetylpyridinium chlorideinduced light scattering in synovial fluid could be abolished by treatment of the specimens with hyaluronate lyase. Thus, in both pathological conditions, light scattering is due to the nearly exclusive presence of hyaluronic acid.
Tab. 7. Relative concentration of hyaluronic acid in synovial fluids from inflammatory and non-inflammatory joint diseases. The differentiation is based on cytologic, clinicalchemical and physicochemical criteria (56) . 0.1 ml of synovial fluid was diluted l : 40 with 0.03 mol/1 NaCl, and 0.5 ml of the dilution was subjected to treatment with hyaluronate lyase, filtered and incubated with N-cetylpyr idinium Chloride äs described in "Methods". 
Discussion
As detailed in the present study the laser nephelometrically recorded formation of complexes between glycosaminoglycans and N-cetylpyridinium Chloride can be utilized under certain conditions for a reliable measurement of total and specific glycosaminoglycans. The method proves sensitive, precise, inexpensive and irelatively simple, and is therefore probably widely applicable. In coiftparison to the previously described turbidimetric measurement of glycosaminoglycans using either N-cetylpyridinium Chloride (48, 49) or cetyltrimethylammoniurn bromide (47) äs complexing agents, the sensitivity of the nephelom etric method is superior$ this is also the case in-the immunologic measurement of proteins with the two procedures. Therefore, the laser nephelometric priiiĉ iple niight also be advantageous for the determination of glycosaminoglycans in low concentrations in tissue extracts (e.g. biopsy specimens), cell culture exträcts, or in fluids available only in small amounts (e.g. amniotic fluid). Laser nephelometry häs recently proved to be useful in the estimation of glycosaminoglycans in human serum (51) . Corripared with the quantitation of glycosaminQglycans by determination of uronic acid, laser nephelometric measurement is much more simple, has an even higher sensitivity and is independent of the type of uronic acid (which is known to influence the carbazole reaction (60)).
The laser nephelometric method is based on the measurement of glycosaminoglycans by virtue of their polyanionic structure. Soine of the dfawbacks of the proposed method are related to the complicated, physico-chemically carefully explored ifiteractions of glycosaminoglycans with quaternäry ammon ium salts (42, 43, 63) . The complex formation is known to be dependent on the ioriic strerigth and the pH of the solution (42) . A precipitating complex does not occur with keratan sulphate in the presence of excess N-cetylpyridinium Chloride (42, 43, 64) . Thus, the lätter type of glycosaminoglycans is not measurable with the nephelometric method (fig, 2) . Furthermore, small moleeular weight fractions of glycosaminoglycans (< octasaccharides) do not form complexes with the organic cations anc& hence, will be not detectable. This fact seems to be noteworthy since glycosaminoglycans in uf ine and serum, prqba= bly in other body fluids äs well* are partly low mölec-ular weight breakdown products of the;,high moleeular weight aggregates present in connective tissue (41) . The most serious complication of the method arises from the dependency of the complex formation not only on the chain length-but also on the degree of $ulphation or Charge detisity of the glycos-Ĵ aminoglycan; an example of this is presented in figure  4 . The effect of the anionic structure of the glycosaminoglycan on the intensity of light scattering in the presence of quaternary ammonium salts faises insuperable difficulties in the selection of appropriate reference glycosaminoglycans (calibration curves) necessary for the calculation of the concentrations of glycosaminoglycans in biological materials. Therefore it is more reliable to determine the relative fractions of various glycosaminoglycans (tab. 7) rather than absolute concentrations. Due to the arbitrary choice of glycosaminoglycan Standards, the latter can be only rough estimates. On the other hand, changes of the relative amount and composition of glycosaminoglycans are detected with sensitivity by the nephelometric method. The specificity of the N-cetylpyridinium chloride-induced light scattering in synovial fluid for glycosaminoglycans is proved by its complete abolition when glycosaminoglycans are destroyed with hyaluronate lyase. In serum, there is a high degrec of laser light scattering due to unspecific reactions of N-cetylpyridinium Chloride with serum components other than glycosaminoglycans (51) . In contrast, synovial fluids did not contain appreciable concentrations of non-glycosaminoglycan molecules that were able to form light scattering complexes with the organiccations. Even high concentrations of DNA and RNA do not interfere with the laser nephelometry of glycosaminoglycans.
The specificity and efficiency of the chemical and enzymatic, laser nephelometrically monitored differentiation of complex glycosaminoglycan mixtures is substantiated by the complete recovery of the individual compounds (tab. 5). The time required for the development of optimal light scattering, between 14 and 18h, delays the performance of the assay in its present form. However, light scattering can be read reproducibly at 3 h if a reduction of sensitivity is accepted. Based on the concentration-dependent differences in the time course of light scattering shown in figure l we currently evaluate a peak rate modification of the kinetic nephelometric assay instead of the fixed-time method described here, in order to prevent prolonged incubation times.
Using the laser nephelometric procedure we demonstrate in synovial fluids of non-inflammatory joint diseases a much higher light scattering due to hyaluronic acid than in those of inflammatory origin. This result accords with previous reports, which describe significantly elevated concentrations of hyaluronate in degenerative joint diseases in comparison to inflammatory articular lesions (e.g. rheumatoid arthritis) (55, 56) . Therefore, the laser nephelometric assay of synovial hyaluronic acid is suggested äs an additional, simple and sensitive laboratory aid in the discrimination between both pathogenetic types of articular effusions.
